日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2024/07/31 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
2024/07/10 | 17 : 15 | RNS Regulatory News | MaxCyte, Inc. Notice of Results | LSE:MXCT | Maxcyte Inc |
2024/07/09 | 17 : 14 | RNS Regulatory News | MaxCyte, Inc. Change of Name of Nominated Adviser and Broker | LSE:MXCT | Maxcyte Inc |
2024/07/03 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. TR-1: Notification of major holdings | LSE:MXCT | Maxcyte Inc |
2024/07/02 | 19 : 18 | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
2024/07/02 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
2024/06/27 | 22 : 34 | RNS Regulatory News | MaxCyte, Inc. Publication of Annual Report | LSE:MXCT | Maxcyte Inc |
2024/06/14 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. Grant of Options and Restricted Stock Units | LSE:MXCT | Maxcyte Inc |
2024/06/12 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. Result of AGM | LSE:MXCT | Maxcyte Inc |
2024/06/11 | 19 : 10 | Alliance News | IN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 shares | LSE:MXCT | Maxcyte Inc |
2024/06/11 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. PDMR Dealing | LSE:MXCT | Maxcyte Inc |
2024/06/03 | 23 : 22 | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
2024/05/29 | 21 : 05 | RNS Regulatory News | MaxCyte, Inc. Participation in Upcoming Investor Conference | LSE:MXCT | Maxcyte Inc |
2024/05/23 | 05 : 51 | Alliance News | IN BRIEF: MaxCyte inks deal with Legend Biotech for tech supply | LSE:MXCT | Maxcyte Inc |
2024/05/22 | 21 : 05 | RNS Regulatory News | MaxCyte, Inc. Signing of Strategic Platform License | LSE:MXCT | Maxcyte Inc |
2024/05/20 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
2024/05/14 | 22 : 55 | RNS Regulatory News | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
2024/05/08 | 17 : 46 | Alliance News | MaxCyte shares rise amid double-digit revenue increase | LSE:MXCT | Maxcyte Inc |
2024/05/08 | 15 : 05 | RNS Regulatory News | MaxCyte, Inc. Filing of Form 10-Q | LSE:MXCT | Maxcyte Inc |
2024/05/08 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. First Quarter Results | LSE:MXCT | Maxcyte Inc |
2024/05/03 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. Notice of AGM | LSE:MXCT | Maxcyte Inc |
2024/05/02 | 01 : 04 | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
2024/04/10 | 21 : 05 | RNS Regulatory News | MaxCyte, Inc. Notice of Results | LSE:MXCT | Maxcyte Inc |
2024/04/03 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. Total Voting Rights and Block Listing Return | LSE:MXCT | Maxcyte Inc |
2024/04/02 | 23 : 19 | Alliance News | TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout | LSE:MXCT | Maxcyte Inc |
2024/04/02 | 21 : 05 | RNS Regulatory News | MaxCyte, Inc. Signing of Strategic Platform License | LSE:MXCT | Maxcyte Inc |
2024/04/02 | 15 : 00 | RNS Regulatory News | MaxCyte, Inc. Exercise of options and PDMR dealing | LSE:MXCT | Maxcyte Inc |
2024/03/20 | 19 : 16 | RNS Regulatory News | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing | LSE:MXCT | Maxcyte Inc |
2024/03/20 | 19 : 05 | RNS Regulatory News | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing | LSE:MXCT | Maxcyte Inc |
2024/03/13 | 20 : 54 | Alliance News | IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25% | LSE:MXCT | Maxcyte Inc |